Valpas, a trailblazer in the hospitality tech industry, has made significant strides towards a bedbug-free future with a substantial €4 million funding boost.
This injection of capital comes as the startup seeks to augment its production capabilities and forge strategic alliances in anticipation of a bustling travel season.
The newly acquired funding will predominantly be directed towards scaling up the production of Valpas’ cutting-edge technology. This ensures rooms maintain continuous protection against bedbugs, meeting burgeoning demand driven by upcoming global events such as the Paris Olympics. Partnerships with travel booking platforms are also in sight to facilitate easier identification of bedbug-safe hotels.
Erik Lindblad, CEO of Zenith VC, commends Valpas for addressing a growing challenge with a seamless solution. He foresees Valpas as a potential global leader, particularly due to its non-chemical approach, adding value for hotels and travel agents as they seek to assure guests of a pest-free experience.
Hotels serve as hotspots for bedbug proliferation, with one in 33 rooms affected, posing a €15 billion financial burden annually. Bedbugs, often transported via luggage, not only infest rooms but also threaten public health by spreading rapidly.
Traditional pesticide products are losing efficacy, with bedbugs nearing complete immunity. This warrants the need for a chemical-free solution to avert a potential public health crisis and mitigate the distress caused by infestations, which include skin rashes and allergic reactions.
Founded in Helsinki in 2017 by a group of visionaries, Valpas offers an unparalleled tech solution to bedbug infestations.
The core of Valpas’ innovation is in their smart anti-bedbug bed legs, which attract bedbugs into a specially designed trap, preventing them from infesting rooms without the use of pesticides.
The system, integrated with an IoT and AI-powered app, enhances detection and disposal efficiency. This chemical-free solution is already embraced by over 300 premium hotels across various regions, including Europe and Japan.
Valpas envisions a future where travel is inherently safer, with hotels serving as bastions against bedbug invasions. The affiliation with high-end hotel brands facilitates the propagation of their innovative safety standard.
Co-founder Martim Gois advocates for the significant social and environmental benefits of such proactive intervention by the hospitality sector, which is rewarded with increased bookings and guest satisfaction.
The company’s bedbug prevention technology marries simplicity with sophistication, ensuring guests experience peace of mind during their stay.
This ingenuity not only prevents bedbugs but also aids hotels in maintaining operational seamlessness, free from the complications posed by chemical solutions.
The €4 million funding empowers Valpas to broaden its market reach and fortify its strategic partnerships to combat the persistent issue of bedbugs in the travel industry.
Valpas is poised to redefine industry standards, offering a comprehensive, tech-driven approach that prioritises guest safety and operational efficiency.
Valpas stands at the forefront of innovation, turning the tide against the global bedbug threat with its ambitious, tech-focused approach.
With its pioneering technology and fresh capital, Valpas is well-equipped to influence the future of hospitality safety, promoting an era where travel is synonymous with peace of mind.
